Nutritional Supplement

Magnesium

  • Heart and Circulatory Health

    Hypertension

    Taking magnesium is effective for lowering blood pressure and has a greater impact in those with higher baseline blood pressure.
    Hypertension
    ×
    Chronic inadequate intake of magnesium increases arterial stiffness and raises the risk of high blood pressure, as well as a range of cardiovascular, metabolic, and neurological disorders. It is estimated 64% of men and 67% of women in the US have insufficient intake of magnesium.1 Observational evidence shows higher dietary magnesium intake and blood magnesium levels are correlated with lower risk of high blood pressure.2,3 Multiple randomized controlled trials show that magnesium supplements can reduce high blood pressure. A meta-analysis that included data from 34 randomized controlled trials with a total of 2,028 participants with normal or high blood pressure found supplementing with 300 mg of magnesium or more daily for two months or longer modestly decreased blood pressure. Overall, magnesium led to an average decrease in systolic blood pressure of 2.00 mmHg and an average decrease in diastolic blood pressure of 1.78 mmHg.4 A meta-analysis of eleven randomized controlled trials with a total of 543 participants, all of whom had chronic metabolic disorders (insulin resistance, pre-diabetes, type 2 diabetes, or coronary artery disease), found magnesium supplementation at doses of 365–450 mg per day lowered systolic and diastolic blood pressures.5 Another meta-analysis included findings from seven trials in which a total of participants were receiving treatment with blood pressure-lowering drugs. In all of the trials, the subjects discontinued their medications and had baseline systolic blood pressures of greater than 155 mmHg before starting magnesium. Magnesium therapy in this population was found to reduce systolic blood pressure by an average of 18.7 mmHg and diastolic blood pressure by an average of 10.9 mmHg.6

    Congestive Heart Failure

    Supplementing with this essential mineral can prevent a deficiency that can lead to heart arrhythmias.
    Congestive Heart Failure
    ×
     

    Magnesium deficiency frequently occurs in people with CHF, and such a deficiency may lead to heart arrhythmias. Magnesium supplements have reduced the risk of these arrhythmias.7 People with CHF are often given drugs that deplete both magnesium and potassium; a deficiency of either of these minerals may lead to an arrhythmia.8 Many doctors suggest magnesium supplements of 300 mg per day.

    Mitral Valve Prolapse

    Magnesium deficiency may be one cause of the symptoms that occur in association with MVP. In one study, people taking magnesium experienced a significant reduction in weakness, chest pain, anxiety, shortness of breath, and palpitations.
    Mitral Valve Prolapse
    ×

    Magnesium deficiency has been proposed as one cause of the symptoms that occur in association with MVP.9 In a study of people with severe MVP symptoms, blood levels of magnesium were low in 60% of cases. Those people with low magnesium levels participated in a double-blind trial, in which they received a placebo or magnesium (500 mg per day for one week, then about 335 mg per day for four weeks). People receiving magnesium experienced a significant reduction in symptoms of weakness, chest pain, anxiety, shortness of breath, and palpitations.10

    Cardiac Arrhythmia

    Supplementing with magnesium may help reduce the number of arrhythmic episodes.
    Cardiac Arrhythmia
    ×
     

    A double-blind trial investigated the effect of oral magnesium supplementation on arrhythmic episodes in people with congestive heart failure. Those people taking 3.2 grams per day of magnesium chloride (equivalent to 384 mg per day of elemental magnesium) had between 23% and 52% fewer occurrences of specific types of arrhythmia during the six-week study, compared with those taking placebo.11 Lower serum concentrations of magnesium were found to be associated with a higher incidence of arrhythmia in a large population study.12 The anti-arrhythmic properties of magnesium appear to be specific. For example, magnesium is clearly able to prevent a drug-induced arrhythmia called torsade de pointes,13 but it does not appear to prevent atrial fibrillation.14 A doctor should supervise any use of magnesium for cardiac arrhythmia.

    Angina

    Taking magnesium may reduce the risk of exercise-induced chest pain.
    Angina
    ×
     

    Magnesium deficiency may be a contributing factor for spasms that occur in coronary arteries, particularly in variant angina.15,16 While studies have used injected magnesium to stop such attacks effectively,17,18 it is unclear whether oral magnesium would be effective in preventing or treating blood vessel spasms. One double-blind study of patients with exercise-induced angina, however, showed that oral magnesium supplementation (365 mg twice a day) for 6 months significantly reduced the incidence of exercise-induced chest pain, compared with a placebo.19

    High Cholesterol

    Magnesium supplementation can be beneficial in reducing cardiovascular risk but is unlikely to lower high cholesterol levels.
    High Cholesterol
    ×
    Magnesium plays an important role in cholesterol synthesis and metabolism, and some research has correlated low magnesium status with high cholesterol levels.20 Magnesium supplementation has been found to have beneficial effects on several aspects of metabolic syndrome and reduce the risks of cardiovascular disease and metabolic disorders, particularly in those with poor magnesium status.21 A meta-analysis that included findings from 12 randomized controlled trials in type 2 diabetic subjects found magnesium supplementation lowered LDL-cholesterol levels, as well as total cholesterol levels, when used for more than 12 weeks.22 However, another meta-analysis that included 18 trials found no effect for magnesium on cholesterol levels in either diabetic or non-diabetic individuals.23

    Stroke

    Magnesium appears to reduce high blood pressure, which may in turn reduce stroke risk.
    Stroke
    ×
     

    Researchers have found an association between diets low in magnesium and increased risk of stroke, an effect explained partially, but not completely, by the ability of magnesium to reduce high blood pressure.24 Protection from stroke associated with drinking water high in magnesium has also been reported.25 Intravenous magnesium given immediately after a stroke has been proposed as a treatment for reducing stroke deaths,26 but results so far have been inconclusive.27

    Intermittent Claudication

    Magnesium may increase blood flow by helping to dilate blood vessels. One trial found that taking magnesium may increase walking distance in people with intermittent claudication.
    Intermittent Claudication
    ×
     

    Magnesium may increase blood flow by helping to dilate blood vessels. A preliminary trial found that magnesium supplementation may increase walking distance in people with intermittent claudication.28 Many doctors suggest that people with atherosclerosis, including those with intermittent claudication, take approximately 250 to 400 mg of magnesium per day.

    In a preliminary trial, supplementing with evening primrose oil (approximately 1,600 mg per day) led to a 10% increase in exercise tolerance in people with intermittent claudication.29

    Chronic Obstructive Pulmonary Disease

    Magnesium is needed for normal function, supplementing with it can make up for the magnesium deficiency commonly caused by prescription drugs taken by people with COPD.
    Chronic Obstructive Pulmonary Disease
    ×
     

    Many prescription drugs commonly taken by people with COPD have been linked to magnesium deficiency, a potential problem because magnesium is needed for normal lung function.30 One group of researchers reported that 47% of people with COPD had a magnesium deficiency.31 In this study, magnesium deficiency was also linked to increased hospital stays. Thus, it appears that many people with COPD may be magnesium deficient, a problem that might worsen their condition; moreover, the deficiency is not easily diagnosed.

    Intravenous magnesium has improved breathing capacity in people experiencing an acute exacerbation of COPD.32 In this double-blind study, the need for hospitalization also was reduced in the magnesium group (28% versus 42% with placebo), but this difference was not statistically significant. Intravenous magnesium is known to be a powerful bronchodilator.33 The effect of oral magnesium supplementation in people with COPD has yet to be investigated.

    Raynaud’s Disease

    Abnormalities of magnesium metabolism have been reported in people with Raynaud’s disease. Magnesium deficiency results in blood-vessel spasm, which may be helped with supplementation.
    Raynaud’s Disease
    ×
     

    Abnormalities of magnesium metabolism have been reported in people with Raynaud’s disease.34 Symptoms similar to those seen with Raynaud’s disease occur in people with magnesium deficiency,35 probably because a deficiency of this mineral results in spasm of blood vessels.36 Some doctors recommend that people with Raynaud’s disease supplement with 200–600 mg of magnesium per day, although no clinical trials support this treatment.

  • Women's Health

    Dysmenorrhea

    Supplementing with magnesium may help keep uterine muscles relaxed.
    Dysmenorrhea
    ×
     

    Magnesium plays a role in controlling muscle tone and could be important in preventing menstrual cramps.37,38 Magnesium supplements have been reported in preliminary and double-blind European research to reduce symptoms of dysmenorrhea.39,40,41 In one of these double-blind trials, women took 360 mg per day of magnesium for three days beginning on the day before menses began.40

    Premenstrual Syndrome

    Supplementing with magnesium may help reduce the risk of mood swings, bloating, breast tenderness, headaches, and other symptoms.
    Premenstrual Syndrome
    ×
     

    Women with PMS have been reported to be at increased risk of magnesium deficiency.42,43 Supplementing with magnesium may help reduce symptoms.44,45 In one double-blind trial using only 200 mg per day for two months, a significant reduction was reported for several symptoms related to PMS (fluid retention, weight gain, swelling of extremities, breast tenderness, and abdominal bloating).46 Magnesium has also been reported to be effective in reducing the symptoms of menstrual migraine headaches.47 While the ideal amount of magnesium has yet to be determined, some doctors recommend 400 mg per day.48 Effects of magnesium may begin to appear after two to three months.

    Pregnancy and Postpartum Support

    Some, though not all, research suggests that supplementing with magnesium may improve pregnancy-induced leg cramps.
    Pregnancy and Postpartum Support
    ×
    A double-blind trial found that supplementing with 100 mg of magnesium three times per day for four weeks improved pregnancy-induced leg cramps.49 However, another double-blind study found that 360 mg of magnesium per day for two weeks did not relieve pregnancy-induced leg cramps.50

    Menopause

    In a preliminary trial, supplementing with magnesium significantly decreased the frequency of hot flashes in women experiencing menopausal symptoms after breast cancer treatment.
    Menopause
    ×
    In a preliminary trial, supplementation with magnesium (250 to 500 mg per day for 4 weeks) significantly decreased the frequency of hot flashes by 47% in women who were experiencing menopausal symptoms after treatment for breast cancer.51 However, a double-blind trial found that magnesium supplements were not beneficial for postmenopausal women with a history of breast cancer who were experiencing hot flashes.52 Therefore, the positive results seen in the preliminary trial may have been due to a placebo effect.
  • Blood Sugar and Diabetes Support

    Type 2 Diabetes

    People with type 2 diabetes tend to have low magnesium levels. Supplementing with magnesium may improve glucose metabolism and help prevent diabetes-related cardiovascular disease.
    Type 2 Diabetes
    ×

    Numerous studies have shown that poor magnesium status is associated with insulin resistance and type 2 diabetes.53,54,55,56 Furthermore, diabetes itself causes increased magnesium loss, resulting in a vicious cycle of dropping magnesium levels and worsening insulin resistance.57,58 Low magnesium levels have also been correlated with poor blood glucose control and increased risk of complications such as heart disease, kidney disease, and nerve damage in those with type 2 diabetes.59,60,61,62,63 Moreover, meta-analyses of randomized controlled trials have concluded that magnesium supplementation can lower blood pressure and decrease the risk of diabetes-related cardiovascular disease in people with type 2 diabetes.64,65

    Taking 250 mg of elemental magnesium (from magnesium oxide, gluconate, and lactate) per day for three months improved glycemic control and insulin sensitivity in a randomized controlled trial with 42 participants with type 2 diabetes.66 In a placebo-controlled trial, patients with diabetes-related kidney failure taking 250 mg of elemental magnesium (from magnesium oxide) per day for 24 weeks had improved vascular health, as well as reduced insulin, total cholesterol, LDL-cholesterol, and C-reactive protein levels, Hgb1c values, and insulin resistance scores, and increased antioxidant capacity.67 However, another placebo-controlled trial that included people with type 2 diabetes and related kidney disease found the combination of 250 mg magnesium (from magnesium oxide) plus 47 mg calcium (from calcium carbonate) per day improved lipid profiles but had no effect on glucose control and worsened insulin resistance after 12 weeks.68 Many doctors recommend that people with diabetes supplement with 200 to 600 mg per day of elemental magnesium from a highly bioavailable magnesium salt without added calcium.

    Type 1 Diabetes

    People with type 1 diabetes tend to have low magnesium levels and supplementing with magnesium may reduce the risk of deficiency-related problems, such as eye damage and neuropathy.
    Type 1 Diabetes
    ×
    People with type 1 diabetes often have low magnesium levels, and low magnesium status is correlated with poor glucose control and increased risk of complications. In magnesium-deficient pregnant women with type 1 diabetes, the lack of magnesium may even account for the high rate of miscarriages and birth defects associated with type 1 diabetes. Some studies have found that magnesium replenishment using supplements can improve blood glucose control and may reduce the risks of certain diabetes complications, such as cardiovascular disease and neuropathy, in children and adults with type 1 diabetes. Many doctors recommend that adults with type 1 diabetes and normal kidney function supplement with 200 to 600 mg of magnesium per day to maintain normal magnesium status; children with type 1 diabetes may benefit from a lower dose.

    Metabolic Syndrome

    People with metabolic syndrome often have low magnesium status and benefit from magnesium supplementation.
    Metabolic Syndrome
    ×
    Low magnesium levels have been associated with increased risk of metabolic syndrome, as well as type 2 diabetes and cardiovascular disease, in multiple observational studies.69 A review of randomized controlled trials investigating the use of magnesium supplements in people with components of metabolic syndrome concluded magnesium has metabolic benefits in individuals with low magnesium levels.70 In one placebo-controlled trial that included 198 participants with metabolic syndrome and low magnesium status, taking 382 mg of elemental magnesium daily for 16 weeks reduced blood pressure, blood glucose levels, and triglyceride levels.71 However, 300 mg of magnesium along with 600 micrograms of chromium and 36 mg of zinc daily for 24 weeks did not impact aspects of metabolic syndrome in a placebo-controlled trial that included people with metabolic syndrome whose baseline magnesium status was not measured.72

    Hypoglycemia

    Research has shown that supplementing with or magnesium can prevent blood sugar levels from falling excessively in people with hypoglycemia.
    Hypoglycemia
    ×
      

    Research has shown that supplementing with chromium (200 mcg per day)73 or magnesium (340 mg per day)74 can prevent blood sugar levels from falling excessively in people with hypoglycemia. Niacinamide (vitamin B3) has also been found to be helpful for hypoglycemic people.75 Other nutrients, including vitamin C, vitamin E, zinc, copper, manganese, and vitamin B6, may help control blood sugar levels in diabetics.76 Since there are similarities in the way the body regulates high and low blood sugar levels, these nutrients might be helpful for hypoglycemia as well, although the amounts needed for that purpose are not known.

    Retinopathy

    Low magnesium levels have been found to be a risk factor for retinopathy in white people with diabetes. Supplementing with magnesium may improve blood levels of the mineral.
    Retinopathy
    ×
     

    Low blood levels of magnesium have been found to be a risk factor for retinopathy in white people with diabetes,77,78 but not in black people with diabetes.79 So far, no studies have determined whether supplementing with magnesium would help prevent the development of retinopathy.

  • Menstrual and PMS Support

    Dysmenorrhea

    Supplementing with magnesium may help keep uterine muscles relaxed.
    Dysmenorrhea
    ×
     

    Magnesium plays a role in controlling muscle tone and could be important in preventing menstrual cramps.80,81 Magnesium supplements have been reported in preliminary and double-blind European research to reduce symptoms of dysmenorrhea.82,83,84 In one of these double-blind trials, women took 360 mg per day of magnesium for three days beginning on the day before menses began.83

    Premenstrual Syndrome

    Supplementing with magnesium may help reduce the risk of mood swings, bloating, breast tenderness, headaches, and other symptoms.
    Premenstrual Syndrome
    ×
     

    Women with PMS have been reported to be at increased risk of magnesium deficiency.85,86 Supplementing with magnesium may help reduce symptoms.87,88 In one double-blind trial using only 200 mg per day for two months, a significant reduction was reported for several symptoms related to PMS (fluid retention, weight gain, swelling of extremities, breast tenderness, and abdominal bloating).89 Magnesium has also been reported to be effective in reducing the symptoms of menstrual migraine headaches.90 While the ideal amount of magnesium has yet to be determined, some doctors recommend 400 mg per day.91 Effects of magnesium may begin to appear after two to three months.

  • Pain Management

    Migraine Headache

    Compared with healthy people, migraine sufferers have been found to have lower magnesium levels. Supplementing with magnesium may reduce migraine frequency and relieve symptoms.
    Migraine Headache
    ×
     

    Compared with healthy people, people with migraines have been found to have lower blood and brain levels of magnesium.92,93,94,95 Preliminary research in a group of women (mostly premenopausal) showed that supplementing with magnesium (usually 200 mg per day) reduced the frequency of migraines in 80% of those treated.96 In a double-blind trial of 81 people with migraines, 600 mg of magnesium per day was significantly more effective than placebo at reducing the frequency of migraines.97 Another double-blind trial found that taking 360 mg of magnesium per day decreased the number of days on which premenstrual migraines occurred.98 One double-blind trial found no benefit from 486 mg of magnesium per day for three months. However, that study defined improvement according to extremely strict criteria, and even some known anti-migraine drugs have failed to show benefit when tested using those criteria.99 Intravenous magnesium has been reported to produce marked and sometimes complete symptom relief during acute migraines, usually within 15 minutes or less.100

    Fibromyalgia

    A preliminary trial found that a combination of magnesium and malic acid might lessen muscle pain in people with fibromyalgia.
    Fibromyalgia
    ×
    In a preliminary trial, supplementing with 300 mg per day of magnesium (as magnesium citrate) improved symptoms in women with fibromyalgia.101 Another preliminary trial found that a combination of magnesium and malic acid might lessen muscle pain in people with fibromyalgia.102 The amounts used in this trial were 300–600 mg of elemental magnesium and 1,200–2,400 mg of malic acid per day, taken for eight weeks. A double-blind trial by the same research group using 300 mg magnesium and 1,200 mg malic acid per day found no reduction in symptoms, however.103 Though these researchers claimed that magnesium and malic acid appeared to have some effect at higher levels (up to 600 mg magnesium and 2,400 mg malic acid per day), the positive effects were not demonstrated under blinded study conditions. Therefore, the evidence supporting the use of these supplements for people with fibromyalgia remains inconclusive.

    Cluster Headache

    People who suffer from cluster headaches often have low blood levels of magnesium, magnesium injections have been shown to bring relief.
    Cluster Headache
    ×
     

    People who suffer from cluster headaches often have low blood levels of magnesium, and preliminary trials104,105 show that intravenous magnesium injections may relieve a cluster headache episode. However, no trials have investigated the effects of oral magnesium supplementation on cluster headaches.

  • Healthy Pregnancy and New Baby

    Gestational Hypertension

    Taking magnesium may prevent gestational hypertension or reduce its severity.
    Gestational Hypertension
    ×

    Magnesium deficiency has also been implicated as a possible cause of GH.106,107,108 Dietary intake of magnesium is below recommended levels for many women during pregnancy.109,106 Magnesium supplementation has been reported to reduce the incidence of GH in preliminary106 and many double-blind trials.112,113,114 In addition to preventing GH, magnesium supplementation has also been reported to reduce the severity of established GH in one study.115 Amounts used in studies on GH range from 165 to 365 mg of supplemental magnesium per day.

    Pregnancy and Postpartum Support

    Some, though not all, research suggests that supplementing with magnesium may improve pregnancy-induced leg cramps.
    Pregnancy and Postpartum Support
    ×
    A double-blind trial found that supplementing with 100 mg of magnesium three times per day for four weeks improved pregnancy-induced leg cramps.114 However, another double-blind study found that 360 mg of magnesium per day for two weeks did not relieve pregnancy-induced leg cramps.115

    Preeclampsia

    Magnesium supplementation has been shown to reduce the incidence of preeclampsia in high-risk women in one trial.
    Preeclampsia
    ×
     

    Magnesium deficiency has been implicated as a possible cause of preeclampsia.116,117,118,119,120 Magnesium supplementation has been shown to reduce the incidence of preeclampsia in high-risk women in one trial,121 but not in another double-blind trial.117

  • Kidney and Urinary Tract Health

    Urinary Incontinence

    In a double blind study, women with urge incontinence reported improvement after supplementing with magnesium.
    Urinary Incontinence
    ×
    In a double blind study, women with urge incontinence took approximately 150 mg of magnesum twice daily for one month, and reported improvement, including fewer episodes of urge incontinence, less frequent urination, and fewer awakenings at night to urinate.122 This confirmed an earlier double-blind study showing that a similar amount of magnesium reduced symptoms of urge incontinence.123
  • Bone Support

    Osteoporosis

    Supplementing with magnesium has been shown to stop bone loss or increased bone mass in people with osteoporosis.
    Osteoporosis
    ×

    In a preliminary study, people with osteoporosis were reported to be at high risk for magnesium malabsorption.124 Both bone125 and blood126 levels of magnesium have been reported to be low in people with osteoporosis. Supplemental magnesium has reduced markers of bone loss in men.127 Supplementing with 250 mg up to 750 mg per day of magnesium arrested bone loss or increased bone mass in 87% of people with osteoporosis in a two-year, preliminary trial.128 Supplementing with magnesium (150 mg per day for one year) also increased bone mass in pre-adolescent and adolescent girls in a double-blind study.129 Some doctors recommend that people with osteoporosis supplement with 350 mg of magnesium per day.

    One trial studying postmenopausal women combined hormone replacement therapy with magnesium (600 mg per day), calcium (500 mg per day), vitamin C, B vitamins, vitamin D, zinc, copper, manganese, boron, and other nutrients for an eight- to nine-month period.130 In addition, participants were told to avoid processed foods, limit protein intake, emphasize vegetable over animal protein, and limit consumption of salt, sugar, alcohol, coffee, tea, chocolate, and tobacco. Bone density increased a remarkable 11%, compared to only 0.7% in women receiving hormone replacement alone.

  • Children's Health

    Attention Deficit–Hyperactivity Disorder

    Some children with ADHD have low magnesium levels. In one trial, children with ADHD and low magnesium status who were given magnesium had a significant decrease in hyperactive behavior.
    Attention Deficit–Hyperactivity Disorder
    ×
     

    Some children with ADHD have lowered levels of magnesium. In a preliminary, controlled trial, children with ADHD and low magnesium status were given 200 mg of magnesium per day for six months.131 Compared with 25 other magnesium-deficient ADHD children, those given magnesium supplementation had a significant decrease in hyperactive behavior.

    Autism

    Some researchers have added magnesium to vitamin B6, reporting that taking both nutrients may have better effects than B6 alone. Doctors will often try this combination for at least three months to see whether these nutrients help autistic children.
    Autism
    ×
     

    Some researchers have added magnesium to vitamin B6, reporting that taking both nutrients may have better effects than taking B6 alone.132 The amount of magnesium—10 to 15 mg per 2.2 pounds of body weight—is high enough to cause diarrhea in some people and should be administered by a doctor. Doctors will often try vitamin B6 or the combination of B6 and magnesium for at least three months to see whether these nutrients help autistic children. In a preliminary trial, one group of researchers found that relatively small daily amounts of magnesium (6 mg per 2.2 pounds of body weight) and vitamin B6 (0.6 mg per 2.2 pounds of body weight) improved symptoms by about 50% in children with autism or a related condition (pervasive developmental disorder).133

  • Allergy and Lung Support

    Asthma

    People with asthma frequently have low magnesium levels. Supplementing with the mineral might help prevent asthma attacks because magnesium can prevent bronchial spasms.
    Asthma
    ×
     

    Magnesium levels are frequently low in asthmatics.134 Current evidence suggests that high dietary magnesium intake may be associated with better lung function and reduced bronchial reactivity. Intravenous injection of magnesium has been reported in most,135,136,137,138 but not all,139 double-blind trials to rapidly halt acute asthma attacks. Magnesium supplements might help prevent asthma attacks because magnesium can prevent spasms of the bronchial passages. In a preliminary trial, 18 adults with asthma took 300 mg of magnesium per day for 30 days and experienced decreased bronchial reactivity.140 However, a double-blind trial investigated the effects of 400 mg per day for three weeks and found a significant improvement in symptoms, but not in objective measures of airflow or airway reactivity.141 The amount of magnesium used in these trials was 300 to 400 mg per day. Children usually take proportionately less based on their body weight, but one study of asthmatic children between the ages of 17 and 19 used 300 mg of magnesium per day.142

  • Digestive Support

    Celiac Disease

    The malabsorption that occurs in celiac disease can lead to multiple nutritional deficiencies. Supplementing with magnesium may correct a deficiency.
    Celiac Disease
    ×
     

    The malabsorption that occurs in celiac disease can lead to multiple nutritional deficiencies. The most common nutritional problems in people with celiac disease include deficiencies of essential fatty acids, iron, vitamin D, vitamin K, calcium, magnesium, and folic acid.143Zinc malabsorption also occurs frequently in celiac disease144 and may result in zinc deficiency, even in people who are otherwise in remission.145 People with newly diagnosed celiac disease should be assessed for nutritional deficiencies by a doctor. Celiac patients who have not yet completely recovered should supplement with a high-potency multivitamin-mineral. Some patients may require even higher amounts of some of these vitamins and minerals—an issue that should be discussed with their healthcare practitioner. Evidence of a nutrient deficiency in a celiac patient is a clear indication for supplementation with that nutrient.

    After commencement of a gluten-free diet, overall nutritional status gradually improves. However, deficiencies of some nutrients may persist, even in people who are strictly avoiding gluten. For example, magnesium deficiency was found in 8 of 23 adults with celiac disease who had been following a gluten-free diet and were symptom-free. When these adults were supplemented with magnesium for two years, their bone mineral density increased significantly.146

  • Energy Support

    Chronic Fatigue Syndrome

    Some researchers have reported that magnesium deficiency is common in people with chronic fatigue syndrome. Supplementing can help make up for a deficiency.
    Chronic Fatigue Syndrome
    ×
     

    NADH (nicotinamide adenine dinucleotide) helps make ATP, the energy source the body runs on. In a double-blind trial, people with CFS received 10 mg of NADH or a placebo each day for four weeks.147 Of those receiving NADH, 31% reported improvements in fatigue, decreases in other symptoms, and improved overall quality of life, compared with only 8% of those in the placebo group. Further double-blind research is needed to confirm these findings.

    Magnesium levels have been reported to be low in CFS sufferers. In a double-blind trial, injections with magnesium improved symptoms for most people.148 Oral magnesium supplementation has improved symptoms in those people with CFS who previously had low magnesium levels, according to a preliminary report, although magnesium injections were sometimes necessary.149 These researchers report that magnesium deficiency appears to be very common in people with CFS. Nonetheless, several other researchers report no evidence of magnesium deficiency in people with CFS.150,151,152 The reason for this discrepancy remains unclear. If people with CFS do consider magnesium supplementation, they should have their magnesium status checked by a doctor before undertaking supplementation. It appears that only people with magnesium deficiency benefit from this therapy.

  • Eye Health Support

    Glaucoma

    In one study, supplementing with magnesium improved vision in people with glaucoma, apparently by enhancing blood flow to the eyes.
    Glaucoma
    ×
     

    Magnesium can dilate blood vessels. One study looked at whether magnesium might improve vision in people with glaucoma by enhancing blood flow to the eyes. In that trial, participants were given 245 mg of magnesium per day. Improvement in vision was noted after four weeks, but the change did not reach statistical significance.153

    Retinopathy

    Low magnesium levels have been found to be a risk factor for retinopathy in white people with diabetes. Supplementing with magnesium may improve blood levels of the mineral.
    Retinopathy
    ×
     

    Low blood levels of magnesium have been found to be a risk factor for retinopathy in white people with diabetes,154,155 but not in black people with diabetes.156 So far, no studies have determined whether supplementing with magnesium would help prevent the development of retinopathy.

  • Sleep Support

    Insomnia

    People with period limb movements during sleep or restless legs syndrome often have sleep problems. In one trial, insomniacs with these conditions slept better after supplementing with magnesium.
    Insomnia
    ×
     

    Some people have difficulty sleeping because of a problem known as period limb movements during sleep (PLMS) or another condition called restless legs syndrome (RLS). In a preliminary trial, people with PLMS or RLS who suffered from insomnia had a significant improvement in sleep efficiency after supplementing with magnesium (about 300 mg each evening for four to six weeks).157

    Restless Legs Syndrome

    Supplementing with magnesium may help relieve insomnia in people with restless leg syndrome.
    Restless Legs Syndrome
    ×
     

    In a preliminary trial, people with period limb movements during sleep (PLMS) or RLS who suffered from insomnia had a significant improvement in sleep efficiency after supplementing with magnesium (about 300 mg each evening for four to six weeks).158

  • Fitness

    Athletic Performance

    Magnesium deficiency can reduce exercise performance and contribute to muscle cramps. Studies suggest that taking magnesium might improve performance, although possibly only for those who are deficient or who are not highly trained athletes.
    Athletic Performance
    ×
    Magnesium deficiency can reduce exercise performance and contribute to muscle cramps, but sub-optimal intake does not appear to be a problem among most groups of athletes.159,160 Controlled trials suggest that magnesium supplementation might improve some aspects of physiology important to sports performance in some athletes,161,162 but controlled and double-blind trials focusing on performance benefits of 212 to 500 mg per day of magnesium have been inconsistent.163,164,165,166,167,168 It is possible that magnesium supplementation benefits only those who are deficient or who are not highly trained athletes. 168,160
  • Menopause Support

    Menopause

    In a preliminary trial, supplementing with magnesium significantly decreased the frequency of hot flashes in women experiencing menopausal symptoms after breast cancer treatment.
    Menopause
    ×
    In a preliminary trial, supplementation with magnesium (250 to 500 mg per day for 4 weeks) significantly decreased the frequency of hot flashes by 47% in women who were experiencing menopausal symptoms after treatment for breast cancer.169 However, a double-blind trial found that magnesium supplements were not beneficial for postmenopausal women with a history of breast cancer who were experiencing hot flashes.170 Therefore, the positive results seen in the preliminary trial may have been due to a placebo effect.
  • Brain Health

    Anxiety

    Many years ago, magnesium was reported to be relaxing for people with mild anxiety. Some doctors recommend soaking in a hot bathtub containing magnesium sulfate crystals (Epsom salts).
    Anxiety
    ×
     

    Many years ago, magnesium was reported to be relaxing for people with mild anxiety.171 Typically, 200 to 300 mg of magnesium are taken two to three times per day. Some doctors recommend soaking in a hot tub containing 1–2 cups of magnesium sulfate crystals (Epsom salts) for 15 to 20 minutes, though support for this approach remains anecdotal.

  • Stress and Mood Management

    Anxiety

    Many years ago, magnesium was reported to be relaxing for people with mild anxiety. Some doctors recommend soaking in a hot bathtub containing magnesium sulfate crystals (Epsom salts).
    Anxiety
    ×
     

    Many years ago, magnesium was reported to be relaxing for people with mild anxiety.172 Typically, 200 to 300 mg of magnesium are taken two to three times per day. Some doctors recommend soaking in a hot tub containing 1–2 cups of magnesium sulfate crystals (Epsom salts) for 15 to 20 minutes, though support for this approach remains anecdotal.

  • Ear Health Support

    Tinnitus

    In a preliminary study, supplementation with magnesium resulted in a statistically significant improvement in symptoms in adults with tinnitus.
    Tinnitus
    ×
    In a preliminary study, supplementation with magnesium (532 mg per day for 3 months) resulted in a statistically significant improvement in symptoms in adults with tinnitus.173 Double-blind trials are needed to confirm the results of this study.
What Are Star Ratings?
×
Reliable and relatively consistent scientific data showing a substantial health benefit.
Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support.

Our proprietary “Star-Rating” system was developed to help you easily understand the amount of scientific support behind each supplement in relation to a specific health condition. While there is no way to predict whether a vitamin, mineral, or herb will successfully treat or prevent associated health conditions, our unique ratings tell you how well these supplements are understood by the medical community, and whether studies have found them to be effective for other people.

For over a decade, our team has combed through thousands of research articles published in reputable journals. To help you make educated decisions, and to better understand controversial or confusing supplements, our medical experts have digested the science into these three easy-to-follow ratings. We hope this provides you with a helpful resource to make informed decisions towards your health and well-being.

×

References

1. Kostov K, Halacheva L. Role of Magnesium Deficiency in Promoting Atherosclerosis, Endothelial Dysfunction, and Arterial Stiffening as Risk Factors for Hypertension. Int J Mol Sci 2018;19:1724.

2. Wu J, Xun P, Tang Q, et al. Circulating magnesium levels and incidence of coronary heart diseases, hypertension, and type 2 diabetes mellitus: a meta-analysis of prospective cohort studies. Nutr J 2017;16:60.

3. Han H, Fang X, Wei X, et al. Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies. Nutr J 2017;16:26.

4. Zhang X, Li Y, Del Gobbo LC, et al. Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertension 2016;68:324–33.

5. Dibaba D, Xun P, Song Y, et al. The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2017;106:921–9.

6. Rosanoff A, Plesset MR. Oral magnesium supplements decrease high blood pressure (SBP>155 mmHg) in hypertensive subjects on anti-hypertensive medications: a targeted meta-analysis.Magnes Res. 2013;26:93–9.

7. Bashir Y, Sneddon JF, Staunton A, et al. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol 1993;72:1156-62.

8. Packer M, Gottlieb SS, Kessler PD. Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. Am J Med 1986;80 (Suppl 4A):23-9.

9. Galland LD, Baker SM, McLellan RK. Magnesium deficiency in the pathogenesis of mitral valve prolapse. Magnesium 1986;5:165-74.

10. Lichodziejewska B, Klos J, Rezler J, et al. Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. Am J Cardiol 1997;79:768-72.

11. Bashir Y, Sneddon JF, Staunton A, et al. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol 1993;72:1156-62.

12. Tsuji H, Venditti FJ, Evans JC, et al. The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study). Am J Cardiol 1994;74:232-5.

13. Tzivoni D, Keren A. Suppression of ventricular arrhythmias by magnesium. Am J Cardiol 1990;65:1397-9 [review].

14. Brugada P. Magnesium: an antiarrhythmic drug, but only against very specific arrhythmias. Eur Heart J 2000;21:1116 [review].

15. Turlapaty P, Altura B. Magnesium deficiency produces spasms of coronary arteries: Relationship to etiology of sudden death ischemic heart disease. Science 1980;208:199-200.

16. Goto K, Yasue H, Okumura K, et al. Magnesium deficiency detected by intravenous loading test in variant angina pectoris. Am J Cardiol 1990;65:709-12.

17. Cohen L, Kitzes R. Magnesium sulfate in the treatment of variant angina. Magnesium 1984;3:46-9.

18. Cohen L, Kitzes R. Prompt termination and/or prevention of cold-pressor-stimulus-induced vasoconstriction of different vascular beds by magnesium sulfate in patients with Prinzmetal's angina. Magnesium 1986;5:144-9.

19. Shechter M, Bairey Merz CN, et al. Effects of oral magnesium therapy on exercise tolerance, exercise-induced chest pain, and quality of life in patients with coronary artery disease. Am J Cardiol 2003;91:517-21.

20. Dos Santos LR, Melo SRS, Severo JS, et al. Cardiovascular Diseases in Obesity: What is the Role of Magnesium? Biol Trace Elem Res 2021;199:4020–7.

21. Guerrero-Romero F, Jaquez-Chairez F, Rodriguez-Moran M. Magnesium in metabolic syndrome: a review based on randomized, double-blind clinical trials. Magnes Res 2016;29:146–53.

22. Asbaghi O, Moradi S, Nezamoleslami S, et al. The Effects of Magnesium Supplementation on Lipid Profile Among Type 2 Diabetes Patients: a Systematic Review and Meta-analysis of Randomized Controlled Trials. Biol Trace Elem Res 2021;199:861–73.

23. Simental-Mendía LE, Simental-Mendía M, Sahebkar A, et al. Effect of magnesium supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 2017;73:525–36.

24. Ascherio A, Rimm EB, Hernan MA, et al. Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation 1998;98:1198-204.

25. Yang CY. Calcium and magnesium in drinking water and risk of death from cerebrovascular disease. Stroke 1998;29:411-4.

26. Muir KW. New experimental and clinical data on the efficacy of pharmacological magnesium infusions in cerebral infarcts. Magnes Res 1998;11:43-56.

27. Muir KW, Lees KR. A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. Stroke 1995;26:1183-8.

28. Neglen P, Overfordt P, Eklof B. Peroral magnesium hydroxide therapy and intermittent claudication. Vasa 1985;14:285-8.

29. Christie SB, Conway N, Pearson HE. Observations on the performance of a standard exercise test by claudicants taking gamma-linolenic acid. J Atheroscler Res 1968;8:83-90.

30. Rolla G, Bucca C, Bugiani M, et al. Hypomagnesemia in chronic obstructive lung disease: effect of therapy. Magnesium Trace Elem 1990;9:132-6.

31. Fiaccadori E, Del Canale S, Coffrini E, et al. Muscle and serum magnesium in pulmonary intensive care unit patients. Crit Care Med 1988;16:751-60.

32. Skorodin MS, Tenholder MF, Yetter B, et al. Magnesium sulfate in exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 1995;155:496-500.

33. Okayama H, Aikawa T, Okayama M, et al. Bronchodilating effect of intravenous magnesium sulfate in bronchial asthma. JAMA 1987;257:1076-8.

34. Leppert J, Aberg H, Levin K, et al. The concentration of magnesium in erythrocytes in female patients with primary Raynaud's phenomenon; fluctuation with the time of year. Angiology 1994;45:283-8.

35. Smith WO, Hammarsten JF, Eliel LP. The clinical expression of magnesium deficiency. JAMA 1960;174:77-8.

36. Turlapaty P, Altura BM. Magnesium deficiency produces spasms of coronary arteries; relationship to etiology of sudden death ischemic heart disease. Science 1980;208:198-200.

37. Durlach J. Neuromuscular and phlebothrombotic clinical aspects of primary magnesium deficiency. Z Ernahrungswiss 1975;14:75-83 [in French].

38. Martignoni E, Nappi G, Facchinetti F, Gennazzani AR. Magnesium in gynecological disorders. Gyn Endocrinol 1988;2(Suppl 2):26 [abstract].

39. Benassi L, Barletta FP, Baroncini L, et al. Effectiveness of magnesium pidolate in the prophylactic treatment of primary dysmenorrhea. Clin Exp Obstet Gynecol 1992;19:176-9.

40. Fontana-Klaiber H, Hogg B. Therapeutic effects of magnesium in dysmenorrhea. Schweiz Rundsch Med Prax 1990;79:491-4 [in German].

41. Seifert B, Wagler P, Dartsch S, et al. Magnesium—a new therapeutic alternative in primary dysmenorrhea. Zentralbl Gynakol 1989;111:755-60 [in German].

42. Abraham GE, Lubran MM. Serum and red cell magnesium levels in patients with premenstrual tension. Am J Clin Nutr 1981;34:2364-6.

43. Sherwood RA, Rocks BF, Stewart A, Saxton RS. Magnesium and the premenstrual syndrome. Ann Clin Biochem 1986;23:667-70.

44. Nicholas A. Traitement du syndrome pre-menstruel et de la dysmenorrhee par l'ion magnesium. in First International Symposium on Magnesium Deficit in Human Pathology, ed. J Durlach. Paris: Springer-Verlag, 1973, 261-3.

45. Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol 1991;78:177-81.

46. Walker AF, De Souza MC, Vickers MF, et al. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health 1998;7:1157-65.

47. Facchinetti F, Sances G, Borella P, et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991;31:298-301.

48. Werbach MR. Premenstrual syndrome: magnesium. Int J Alternative Complementary Med 1994;Feb:29 [review].

49. Supakatisant C, Phupong V. Oral magnesium for relief in pregnancy-induced leg cramps: a randomised controlled trial. <em>Matern Child Nutr</em> 2012 Aug 22 [Epub ahead of print].

50. Nygaard IH, Valbo A, Pethick SV, Bohmer T. Does oral magnesium substitution relieve pregnancy-induced leg cramps? <em>Eur J Obstet Gynecol Reprod Biol</em> 2008;141:23-6.

51. REF:Park H, Parker GL, Boardman CH, et al. A pilot phase II trial of magnesium supplements to reduce menopausal hot flashes in breast cancer patients. Support Care Cancer 2011;19:859-63.

52. Park H, Qin R, Smith TJ, Atherton PJ, et al. North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes. Menopause 2014;Nov 24:[Epub ahead of print].

53. Ozcaliskan Ilkay H, Sahin H, Tanriverdi F, Samur G. Association Between Magnesium Status, Dietary Magnesium Intake, and Metabolic Control in Patients with Type 2 Diabetes Mellitus. J Am Coll Nutr 2019;38:31–9.

54. Hruby A, Guasch-Ferre M, Bhupathiraju S, et al. Magnesium Intake, Quality of Carbohydrates, and Risk of Type 2 Diabetes: Results From Three U.S. Cohorts. Diabetes Care 2017;40:1695–702.

55. Chen S, Jin X, Liu J, et al. Association of Plasma Magnesium with Prediabetes and Type 2 Diabetes Mellitus in Adults. Sci Rep 2017;7:12763.

56. Fang X, Han H, Li M, et al. Dose-Response Relationship between Dietary Magnesium Intake and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Regression Analysis of Prospective Cohort Studies. Nutrients 2016;8.

57. Kostov K. Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling. Int J Mol Sci 2019;20.

58. Barbagallo M, Dominguez L. Magnesium and type 2 diabetes. World J Diabetes 2015;6:1152–7.

59. Kumar P, Bhargava S, Agarwal P, et al. Association of serum magnesium with type 2 diabetes mellitus and diabetic retinopathy. J Family Med Prim Care 2019;8:1671–7.

60. Joy S, George T, Siddiqui K. Low magnesium level as an indicator of poor glycemic control in type 2 diabetic patients with complications. Diabetes Metab Syndr 2019;13:1303–7.

61. Zhang Q, Ji L, Zheng H, et al. Low serum phosphate and magnesium levels are associated with peripheral neuropathy in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2018;146:1–7.

62. Gant C, Soedamah-Muthu S, Binnenmars S, et al. Higher Dietary Magnesium Intake and Higher Magnesium Status Are Associated with Lower Prevalence of Coronary Heart Disease in Patients with Type 2 Diabetes. Nutrients 2018;10.

63. Bherwani S, Jibhkate S, Saumya A, et al. Hypomagnesaemia: a modifiable risk factor of diabetic nephropathy. Horm Mol Biol Clin Investig 2017;29:79–84.

64. Dibaba D, Xun P, Song Y, et al. The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2017;106:921–9.

65. Verma H, Garg R. Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis. J Hum Nutr Diet 2017;30:621–33.

66. ELDerawi W, Naser I, Taleb M, Abutair A. The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients. Nutrients 2018;11.

67. Talari H, Zakizade M, Soleimani A, et al. Effects of magnesium supplementation on carotid intima-media thickness and metabolic profiles in diabetic haemodialysis patients: a randomised, double-blind, placebo-controlled trial. Br J Nutr 2019;121:809–17.

68. Sadeghian M, Azadbakht L, Khalili N, et al. Oral Magnesium Supplementation Improved Lipid Profile but Increased Insulin Resistance in Patients with Diabetic Nephropathy: a Double-Blind Randomized Controlled Clinical Trial. Biol Trace Elem Res 2019.

69. Severino P, Netti L, Mariani M, et al. Prevention of Cardiovascular Disease: Screening for Magnesium Deficiency. Cardiol Res Pract 2019:4874921.

70. Guerrero-Romero F, Jaquez-Chairez F, Rodriguez-Moran M. Magnesium in metabolic syndrome: a review based on randomized, double-blind clinical trials. Magnes Res 2016;29:146–53.

71. Rodriguez-Moran M, Simental-Mendia L, Gamboa-Gomez C, Guerrero-Romero F. Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Adv Chronic Kidney Dis 2018;25:261–6.

72. Kim H, Kim S, Eun Y, Song S. Effects of zinc, magnesium, and chromium supplementation on cardiometabolic risk in adults with metabolic syndrome: A double-blind, placebo-controlled randomised trial. J Trace Elem Med Biol 2018;48:166–71.

73. Anderson RA et al. Chromium supplementation of humans with hypoglycemia. Fed Proc 1984;43:471.

74. Stebbing JB et al. Reactive hypoglycemia and magnesium. Magnesium Bull 1982;2:131-4.

75. Shansky A. Vitamin B3 in the alleviation of hypoglycemia. Drug Cosm Ind 1981;129(4):68-69,104-5.

76. Gaby AR, Wright JV. Nutritional regulation of blood glucose. J Advancement Med 1991;4:57-71.

77. Jialal I, Joubert SM. The biochemical profile in Indian patients with non-insulin-dependent diabetes in the young with retinopathy. Diabetes Metabol 1985;11:262-5.

78. McNair P, Christiansen C, Madsbad S, et al. Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes 1978;27:1075-8.

79. Erasmus RT, Olukoga AO, Alanamu RA, et al. Plasma magnesium and retinopathy in black African diabetics. Trop Geogr Med 1989;41:234-7.

80. Durlach J. Neuromuscular and phlebothrombotic clinical aspects of primary magnesium deficiency. Z Ernahrungswiss 1975;14:75-83 [in French].

81. Martignoni E, Nappi G, Facchinetti F, Gennazzani AR. Magnesium in gynecological disorders. Gyn Endocrinol 1988;2(Suppl 2):26 [abstract].

82. Benassi L, Barletta FP, Baroncini L, et al. Effectiveness of magnesium pidolate in the prophylactic treatment of primary dysmenorrhea. Clin Exp Obstet Gynecol 1992;19:176-9.

83. Fontana-Klaiber H, Hogg B. Therapeutic effects of magnesium in dysmenorrhea. Schweiz Rundsch Med Prax 1990;79:491-4 [in German].

84. Seifert B, Wagler P, Dartsch S, et al. Magnesium—a new therapeutic alternative in primary dysmenorrhea. Zentralbl Gynakol 1989;111:755-60 [in German].

85. Abraham GE, Lubran MM. Serum and red cell magnesium levels in patients with premenstrual tension. Am J Clin Nutr 1981;34:2364-6.

86. Sherwood RA, Rocks BF, Stewart A, Saxton RS. Magnesium and the premenstrual syndrome. Ann Clin Biochem 1986;23:667-70.

87. Nicholas A. Traitement du syndrome pre-menstruel et de la dysmenorrhee par l'ion magnesium. in First International Symposium on Magnesium Deficit in Human Pathology, ed. J Durlach. Paris: Springer-Verlag, 1973, 261-3.

88. Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol 1991;78:177-81.

89. Walker AF, De Souza MC, Vickers MF, et al. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health 1998;7:1157-65.

90. Facchinetti F, Sances G, Borella P, et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991;31:298-301.

91. Werbach MR. Premenstrual syndrome: magnesium. Int J Alternative Complementary Med 1994;Feb:29 [review].

92. Gallai V, Sarchielli P, Coata G, et al. Serum and salivary magnesium levels in migraine. Results in a group of juvenile patients. Headache 1992;32:132-5.

93. Baker B. New research approach helps clarify magnesium/migraine link. Family Pract News 1993;Aug 15:16.

94. Barbiroli B, Lodi R, Cortelli P, et al. Low brain free magnesium in migraine and cluster headache: an interictal study by in vivo phosphorus magnetic resonance spectroscopy on 86 patients. Cephalalgia 1997;17:254.

95. Mazzotta G, Sarchielli P, Alberti A, Gallai V. Intracellular Mg++ concentration and electromyographical ischemic test in juvenile headache. Cephalalgia 1999;19:802-9.

96. Weaver K. Magnesium and migraine. Headache 1990;30:168 [letter].

97. Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996;16:257-63.

98. Facchinetti F, Sances G, Borella P, et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991;31:298-301.

99. Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the prophylaxis of migraine—a double-blind placebo-controlled study. Cephalalgia 1996;16:436-40.

100. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulphate relieves migraine attacks in patients with low serum ionized magnesium levels: a pilot study. Clin Sci 1995;89:633-6.

101. Bagis S, Karabiber M, As I, et al. Is magnesium citrate treatment effective on pain, clinical parameters and functional status in patients with fibromyalgia? Rheumatol Int 2013;33:167–72.

102. Abraham G, Flechas J. Management of fibromyalgia: Rationale for the use of magnesium and malic acid. J Nutr Med 1992;3:49-59.

103. Russell IJ, Michalek J, Flechas J, et al. Treatment of fibromyalgia syndrome with SuperMalic: A randomized, double-blind, placebo-controlled, crossover pilot study. J Rheumatol 1995;22(5):953-7.

104. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulfate relieves cluster headaches in patients with low serum ionized magnesium levels. Headache 1995;35:597-600.

105. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache 1996;36:154-60.

106. Wynn A, Wynn M. Magnesium and other nutrient deficiencies as possible causes of hypertension and low birthweight. Nutr Health 1988;6:69-88.

107. Conradt A. Current concepts in the pathogenesis of gestosis with special reference to magnesium deficiency. Z Geburtshilfe Perinatol 1984;188:49-58 [review] [in German].

108. Leela R, Yasodhara P, Ramaraju MBBS, Ramaraju LA. Calcium and magnesium in pregnancy. Nutr Res 1991;11:1231-6.

109. Makrides M, Crowther CA. Magnesium supplementation in pregnancy. Cochrane Database Syst Rev 2000;2:CD000937 [review].

110. Li S, Tian H. Oral low-dose magnesium gluconate preventing pregnancy induced hypertension. Chung Hua Fu Chan Ko Tsa Chih 1997;32:613-5 [in Chinese].

111. D'Almeida A, Caretr JP, Anatol A, Prost C. Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docosahexaenoic acid) versus magnesium, and versus placebo in preventing pre-eclampsia. Women Health 1992;19:117-31.

112. Bullarbo M, Odman N, Nestler A, et al. Magnesium supplementation to prevent high blood pressure in pregnancy: a randomised placebo control trial. Arch Gynecol Obstet 2013;288:1269–74.

113. Rudnicki M, Frolich A, Rasmussen WF, McNair P. The effect of magnesium on maternal blood pressure in pregnancy-induced hypertension. A randomized double-blind placebo-controlled trial. Acta Obstet Gynecol Scand 1991;80:445-50.

114. Supakatisant C, Phupong V. Oral magnesium for relief in pregnancy-induced leg cramps: a randomised controlled trial. <em>Matern Child Nutr</em> 2012 Aug 22 [Epub ahead of print].

115. Nygaard IH, Valbo A, Pethick SV, Bohmer T. Does oral magnesium substitution relieve pregnancy-induced leg cramps? <em>Eur J Obstet Gynecol Reprod Biol</em> 2008;141:23-6.

116. Wynn A, Wynn M. Magnesium and other nutrient deficiencies as possible causes of hypertension and low birthweight. Nutr Health 1988;6:69-88.

117. Spatling L, Spatling G. Magnesium supplementation in pregnancy: a double-blind study. Br J Obstet Gynaecol 1988;950:120-5.

118. Sibai BM, Villar MA, Bray E. Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstet Gynecol 1989;161:115-9.

119. Standley CA, Whitty JE, Mason BA, Cotton DB. Serum ionized magnesium levels in normal and preeclamptic gestation. Obstet Gynecol 1997;89:24-7.

120. Handwerker SM, Altura BT, Altura BM. Ionized serum magnesium and potassium levels in pregnant women with preeclampsia and eclampsia. J Reprod Med 1995;40:201-8.

121. Conradt A, Weidinger H, Algayer G. Magnesium deficiency, a possible cause of pre-eclampsia: reduction of frequency of premature rupture of membranes and premature or small-for-date deliveries after magnesium supplementation. J Am Coll Nutr 1985;4:321.

122. Boschert S. Milk of magnesia may help ease urinary urge incontinence. Fam Pract News 2003;33:46.

123. Gordon D, Groutz A, Ascher-Landsberg J, et al. Double-blind, placebo-controlled study of magnesium hydroxide for treatment of sensory urgency and detrusor instability: preliminary results. Br J Obstet Gynaecol 1998;105:667-9.

124. Cohen L, Laor A, Kitzes R. Magnesium malabsorption in postmenopausal osteoporosis. Magnesium 1983;2:139-43.

125. Cohen L, Kitzes R. Infrared spectroscopy and magnesium content of bone mineral in osteoporotic women. Isr J Med Sci 1981;17:1123-5.

126. Geinster JY, Strauss L, Deroisy R, et al. Preliminary report of decreased serum magnesium in postmenopausal osteoporosis. Magnesium 1989;8:106-9.

127. Dimai H-P, Porta S, Wirnsberger G, et al. Daily oral magnesium supplementation suppresses bone turnover in young adult males. J Clin Endocrinol Metab 1998;83:2742-8.

128. Stendig-Lindberg G, Tepper R, Leichter I. Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis. Magnesium Res 1993;6:155-63.

129. Carpenter TO, DeLucia MC, Zhang JH, et al. A randomized controlled study of effects of dietary magnesium oxide supplementation on bone mineral content in healthy girls. J Clin Endocrinol Metab 2006;91:4866-72.

130. Abraham GE, Grewal H. A total dietary program emphasizing magnesium instead of calcium. J Reprod Med 1990;35:503-7.

131. Starobrat-Hermelin B, Kozielec T. The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test. Magnes Res 1997;10:149-56.

132. Martineau J, Barthelemy C, Garreau B, Lelord G. Vitamin B6, magnesium, and combined B6-Mg: therapeutic effects in childhood autism. Biol Psychiatr 1985;20:467-78.

133. Mousain-Bosc M, Roche M, Polge A, et al. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. II. Pervasive developmental disorder-autism. Magnes Res 2006;19:53-62.

134. Haury VG. Blood serum magnesium in bronchial asthma and its treatment by the administration of magnesium sulfate. J Lab Clin Med 1940;26:340-4.

135. Skobeloff EM, Spivey WH, McNamara RM, Greenspon L. Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. JAMA 1989;262:1210-3.

136. Brunner EH, Delabroise AM, Haddad ZH. Effect of parenteral magnesium on pulmonary function, plasma cAMP, and histamine in bronchial asthma. J Asthma 1985;22:3-11.

137. Rolla G, Bucca C, Caria E, et al. Acute effect of intravenous magnesium sulfate on airway obstruction of asthmatic patients. Ann Allergy 1988;61:388-91.

138. Hill JM, Britton J. Effect of intravenous magnesium sulphate on airway calibre and airway reactivity to histamine in asthmatic subjects. Br J Clin Pharmacol 1996;42:629-31.

139. Bernstein WK, Khastgir T, Khastgir A, et al. Lack of effectiveness of magnesium in chronic stable asthma. A prospective, randomized, double-blind, placebo-controlled, crossover trial in normal subjects and in patients with chronic stable asthma. Arch Intern Med 1995;155:271-6.

140. Rylander R, Dahlberg C, Rubenowitz E. Magnesium supplementation decreases airway responsiveness among hyperreactive subjects. Magnesium-Bulletin 1997;19:4-6.

141. Hill J, Micklewright A, Lewis S, Britton J. Investigation of the effect of short-term change in dietary magnesium intake in asthma. Eur Respir J 1997;10:2225-9.

142. Gontijo-Amaral C, Ribeiro MAGO, Gontijo LSC, et al. Oral magnesium supplementation in asthmatic children: a double-blind randomized placebo-controlled trial. Eur J Clin Nutr 2007;61:54-60.

143. Connon JJ. Celiac disease. In: Shils ME, Olson JA, Shike M, eds. Modern Nutrition in Health and Disease, 8th ed. Philadelphia: Lea & Febiger, 1994, 1062.

144. Crofton RW, Glover SC, Ewen SWB, et al. Zinc absorption in celiac disease and dermatitis herpetiformis: a test of small intestinal function. Am J Clin Nutr 1983;38:706-12.

145. Solomons NW, Rosenberg IH, Sandstead HH. Zinc nutrition in celiac sprue. Am J Clin Nutr 1976;29:371-5.

146. Rude RK, Olerich M. Magnesium deficiency: possible role in osteoporosis associated with gluten-sensitive enteropathy. Osteoporos Int 1996;6:453-61.

147. Forsyth LM, Preuss HG, MacDowell AL, et al. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol 1999;82:185-91.

148. Cox IM, Campbell MJ, Dowson D. Red blood cell magnesium and chronic fatigue syndrome. Lancet 1991;337:757-60.

149. Howard JM, Davies S, Hunnisett A. Magnesium and chronic fatigue syndrome. Lancet 1992;340:426.

150. Clague JE, Edwards RH, Jackson MJ. Intravenous magnesium loading in chronic fatigue syndrome. Lancet 1992;340:124-5.

151. Gantz NM. Magnesium and chronic fatigue. Lancet 1991;338:66 [letter].

152. Hinds G, Bell NP, McMaster D, McCluskey DR. Normal red cell magnesium concentrations and magnesium loading tests in patients with chronic fatigue syndrome. Ann Clin Biochem 1994;31(Pt. 5):459-61.

153. Gaspar AZ, Gasser P, Flammer J. The influence of magnesium on visual field and peripheral vasospasm in glaucoma. Ophthalmologica 1995;209:11-3.

154. Jialal I, Joubert SM. The biochemical profile in Indian patients with non-insulin-dependent diabetes in the young with retinopathy. Diabetes Metabol 1985;11:262-5.

155. McNair P, Christiansen C, Madsbad S, et al. Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes 1978;27:1075-8.

156. Erasmus RT, Olukoga AO, Alanamu RA, et al. Plasma magnesium and retinopathy in black African diabetics. Trop Geogr Med 1989;41:234-7.

157. Hornyak M, Voderholzer U, Hohagen F, et al. Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study. Sleep 1998;21:501-5.

158. Hornyak M, Voderholzer U, Hohagen F, et al. Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: an open pilot study. Sleep 1998;21:501-5.

159. McDonald R, Keen CL. Iron, zinc and magnesium nutrition and athletic performance. Sports Med 1988;5:171-84 [review].

160. Lukaski HC. Magnesium, zinc, and chromium nutriture and physical activity. Am J Clin Nutr 2000;72:585S-93S [review].

161. Golf SW, Bohmer D, Nowacki PE. Is magnesium a limiting factor in competitive exercise? A summary of relevant scientific data. In: Golf S, Dralle D, Vecchiet L, eds. Magnesium 1993. London: John Libbey & Company, 1993:209-20.

162. Ripari P, Pieralisi G, Giamberardino MA, Vecchiet L. Effects of magnesium picolinate on some cardiorespiratory submaximal effort parameters. Magnes Res 1989;2:70-4.

163. Weller E, Bachert P, Meinck HM, et al. Lack of effect of oral Mg-supplementation on Mg in serum, blood cells, and calf muscle. Med Sci Sports Exerc 1998;30:1584-91.

164. Brilla LR, Haley TF. Effect of magnesium supplementation on strength training in humans. J Am Coll Nutr 1992;11:326-9.

165. Golf SW, Bender S, Gruttner J. On the significance of magnesium in extreme physical stress. Cardiovasc Drugs Ther 1998;12(Suppl 2):197-202.

166. Manore M, Merkel J, Helleksen JM, et al. Longitudinal changes in magnesium status in untrained males: effect of two different 12-week exercise training programs and magnesium supplementation. In: Kies CV, Driskell JA, eds. Sports nutrition: minerals and electrolytes. Boca Raton, FL: CRC Press, 1995:179-87.

167. Brilla LR, Gunter KB. Effect of magnesium supplementation on exercise time to exhaustion. Med Exer Nutr Health 1995;4:230-3.

168. Finstad EW, Newhouse IJ, Lukaski HC, et al. The effects of magnesium supplementation on exercise performance. Med Sci Sports Exerc 2001;33:493-8.

169. REF:Park H, Parker GL, Boardman CH, et al. A pilot phase II trial of magnesium supplements to reduce menopausal hot flashes in breast cancer patients. Support Care Cancer 2011;19:859-63.

170. Park H, Qin R, Smith TJ, Atherton PJ, et al. North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes. Menopause 2014;Nov 24:[Epub ahead of print].

171. Weston PG et al. Magnesium sulfate as a sedative. Am J Med Sci 1923;165:431-3.

172. Weston PG et al. Magnesium sulfate as a sedative. Am J Med Sci 1923;165:431-3.

173. Cevette MJ, Barrs DM, Patel A, et al. Phase 2 study examining magnesium-dependent tinnitus. Int Tinnitus J 2011;16:168-73.

174. Gaby, AR. Nutritional Medicine. Concord, NH: Fritz Perlberg Publishing, 2011.

175. Fox CH, Ramsoomair D, Mahoney MC, et al. An investigation of hypomagnesemia among ambulatory urban African Americans. J Fam Pract 1999;48:636-9.

176. Kisters K, Schodjaian K, Tokmak F, et al. Effect of ethanol on blood pressure—role of magnesium. Am J Hypertens 2000;13:455-6 [letter].

177. Weisinger JR, Bellorin-font E. Magnesium and phosphorus.Lancet 1998;352:391-6 [review].

Copyright © 2024 TraceGains, Inc. All rights reserved.

Learn more about TraceGains, the company.

The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2024.

Log In

You need to log into the site to use this feature

Create A Free Account To Use Medicine Chest

This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.

Benefits Include:

Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Medication information
Pill & refill reminders
Medication journal & mood log

Sign up to use Medicine Chest

Create A Free Account To Use this feature

This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.

Benefits Include:

Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Medication information
Pill & refill reminders
Medication journal & mood log

Sign up to use this feature

You will be redirected to your program in 5 seconds.

Hi there.

Our Terms and Conditions and Privacy Policy have recently been updated.

Learn More


I Accept

By declining you will be logged out of your account

;